Morgan Stanley’s New York Life Investments ETF Trust NYLIM Global Equity R&D Leaders ETF WRND Stock Holding History

Morgan Stanley’s Portfolio WRND Stock Details WRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42	Hold	1	–	–	﹤0.01%	8144
2026 Q1	$36	Buy	+1	New	+$38	﹤0.01%	8053

Other funds holding WRND

NYLIM

New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Morgan Stanley's WRND Position: Q2 2026 in Review

Morgan Stanley held its New York Life Investments ETF Trust NYLIM Global Equity R&D Leaders ETF (WRND) position steady in Q2 2026 at 1 share worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #8144.

Morgan Stanley first reported a position in WRND in Q1 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold WRND as of Q2 2026.

Morgan Stanley held 1 share of New York Life Investments ETF Trust NYLIM Global Equity R&D Leaders ETF worth $42 as of Q2 2026.
Morgan Stanley left its New York Life Investments ETF Trust NYLIM Global Equity R&D Leaders ETF share count unchanged in Q2 2026.
New York Life Investments ETF Trust NYLIM Global Equity R&D Leaders ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8144 holding.
Morgan Stanley first reported a position in New York Life Investments ETF Trust NYLIM Global Equity R&D Leaders ETF in Q1 2026 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM Global Equity R&D Leaders ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.